Mkts

Rhythm Pharmaceuticals, Inc.

NASDAQ: RYTM
$89.47+0.20 (+0.22%)
As of Oct 26, 4:00 PM ET

Key statistics

Day range
89.0090.81
52-week range
74.50122.20
Today
Open90.07
Previous close89.47
Volume—
Valuation
Market cap6.18B
P/E ratio—
EPS (TTM)-3.05
Income & risk
Dividend / yield—
Beta2.15
Avg volume736.5K
Discussion

RYTM News

Stories mentioning RYTM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue60,11257,25351,29848,50232,70441,83033,25129,078
Cost of Goods Sold7,1574,8025,4995,5433,6483,7863,8282,947
Gross Profit52,95552,45145,79942,95929,05638,04429,42326,131
Operating Expenses
Research & Development41,72542,03246,02742,30836,97341,16737,93130,194
Sales General & Admin63,59157,48252,42545,94739,08738,13035,37736,415
Total Operating Expenses
Operating Income (Loss)(52,361)(47,063)(52,653)(45,296)(47,004)(41,253)(43,885)(40,478)
Interest Income
Interest Expense
Other Expense(1,704)58.00274.001,576(644.00)325.001,088302.00
Pretax Income(55,094)(47,536)(52,793)(46,295)(49,418)(43,417)(43,985)(31,782)
Tax Provision545.00(31.00)111.00337.0080.00(89.00)(344.00)479.00
Net Income (Loss)(55,639)(47,505)(52,904)(46,632)(49,498)(43,328)(43,641)(32,261)
Earnings Per Share (Basic)(0.83)(0.73)(0.82)(0.75)(0.81)(0.71)(0.73)(0.55)
Earnings Per Share (Diluted)(0.83)(0.73)(0.82)(0.75)(0.81)(0.71)(0.73)(0.55)
Weighted Average Shares Outstanding (Basic)67,97464,98466,26163,68463,05960,99561,22061,012
Weighted Average Shares Outstanding (Diluted)67,97464,98466,26163,68463,05960,99561,22061,012

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RYTM

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a stock listed on the Nasdaq Stock Market under the ticker symbol RYTM. It last traded at $89.47 (Oct 26, 2026, 4:00 PM ET), up 0.2% on the day. That gives Rhythm Pharmaceuticals a market capitalisation of $6.2B.

Over the past 52 weeks RYTM has traded between $74.50 and $122.20.

Revenue for the quarter ended Mar 31, 2026 was $60.1M; a net loss of $55.6M. Revenue was up 83.8% from $32.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$60.1M-$55.6M-92.6%
Dec 31, 2025$57.3M-$47.5M-83.0%
Sep 30, 2025$51.3M-$52.9M-103.1%
Jun 30, 2025$48.5M-$46.6M-96.1%

From Rhythm Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…